Viewing StudyNCT05737563



Ignite Creation Date: 2024-05-06 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05737563
Status: RECRUITING
Last Update Posted: 2024-01-23
First Post: 2023-02-12

Brief Title: PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University

Conditions & Keywords Data

Conditions:
Name
Esophageal Squamous Cell Carcinoma Abdominal Stage 0
Keywords:
Name View
Esophageal Squamous Cell Carcinoma View
PD-1 inhibitor View
Capecitabine View
Irinotecan View
Second-line View